President Trump signed an executive order Monday directing a sweeping overhaul of the childhood vaccine schedule, trimming the list of shots routinely recommended for all children from 18 diseases to 11 and pushing the remaining seven into a parent-and-doctor "shared clinical decision-making" category. The order, titled "Delivering Gold Standard Childhood Vaccine Recommendations for Americans," also calls for breaking the combined measles-mumps-rubella (MMR) shot into three separate single-dose injections given at different visits.

The directive tasks the Department of Health and Human Services, through its Task Force on Safer Childhood Vaccines, with presenting Trump a formal plan for the changes and continuously reevaluating the risk-benefit profile of every vaccine on the childhood schedule. It also directs HHS to promote state-level policies expanding parental authority, religious exemptions and disability accommodations around vaccination requirements.

AUTISM CLAIMS DRAW SWIFT BACKLASH

Trump linked the order to autism rates during a signing-ceremony appearance, a claim public health researchers have repeatedly found no credible scientific support for, according to CNN. Pediatricians' groups and former federal health officials warned the changes could leave more children vulnerable to preventable diseases by delaying protection and adding extra doctor visits that lower-income families may struggle to schedule.

SPACING OUT SHOTS DOESN'T MAKE THEM SAFER — IT JUST LEAVES KIDS UNPROTECTED LONGER, CRITICS ARGUE.

The order builds on months of upheaval at HHS under Secretary Robert F. Kennedy Jr., who has repeatedly questioned the safety of the existing vaccine schedule despite decades of clinical data supporting it, per the Washington Post. Supporters of the order frame it as restoring choice to parents; opponents call it a dangerous politicization of settled science.

States, insurers and school districts are now bracing for confusion over which shots remain mandatory for enrollment. Legal challenges from medical associations are considered likely in the coming weeks, and HHS has not yet published a timeline for when the new recommendations take effect nationwide.